Literature DB >> 16527365

The attribution of incentive salience to a stimulus that signals an intravenous injection of cocaine.

Jason M Uslaner1, Martin J Acerbo, Samantha A Jones, Terry E Robinson.   

Abstract

A central premise of a number of theories of addiction is that discrete environmental stimuli repeatedly paired with drugs of abuse acquire incentive salience as a result of Pavlovian learning. There is, however, no unequivocal evidence supporting this assumption. Thus, we employed a Pavlovian conditioning procedure known to imbue non-drug reinforcers with incentive salience and extended it to study the effects of intravenous cocaine. Specifically, we examined whether a cue paired with intravenous cocaine administration would come to elicit approach towards it (sign-tracking), even if no behavioral response were required to receive the cue or drug. We found that when a cue was paired with intravenous cocaine delivery (but not when it was unpaired) rats came to approach and investigate the cue, and did so with increasing rapidity. We conclude that Pavlovian learning can imbue drug-paired cues with incentive salience, making them attractive and "wanted" stimuli. Delineating the neurobiological mechanisms responsible for this process will be important for understanding and treating drug addiction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527365     DOI: 10.1016/j.bbr.2006.02.001

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  64 in total

Review 1.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats.

Authors:  Shelly B Flagel; Stanley J Watson; Terry E Robinson; Huda Akil
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

Review 3.  The nucleus accumbens and Pavlovian reward learning.

Authors:  Jeremy J Day; Regina M Carelli
Journal:  Neuroscientist       Date:  2007-04       Impact factor: 7.519

4.  Goal- and signal-directed incentive: conditioned approach, seeking, and consumption established with unsweetened alcohol in rats.

Authors:  Marvin D Krank; Susan O'Neill; Kyna Squarey; Jackie Jacob
Journal:  Psychopharmacology (Berl)       Date:  2007-10-30       Impact factor: 4.530

Review 5.  Affective neuroscience of pleasure: reward in humans and animals.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

6.  Individual differences in the attribution of incentive salience to a reward-related cue: influence on cocaine sensitization.

Authors:  Shelly B Flagel; Stanley J Watson; Huda Akil; Terry E Robinson
Journal:  Behav Brain Res       Date:  2007-07-21       Impact factor: 3.332

7.  Effects of rat strain and method of inducing ethanol drinking on Pavlovian-Instrumental-Transfer with ethanol-paired conditioned stimuli.

Authors:  R J Lamb; Brett C Ginsburg; Alexander Greig; Charles W Schindler
Journal:  Alcohol       Date:  2019-01-11       Impact factor: 2.405

8.  A classically conditioned cocaine cue acquires greater control over motivated behavior in rats prone to attribute incentive salience to a food cue.

Authors:  Lindsay M Yager; Terry E Robinson
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

9.  The effect of nicotine on sign-tracking and goal-tracking in a Pavlovian conditioned approach paradigm in rats.

Authors:  Matthew I Palmatier; Kimberley R Marks; Scott A Jones; Kyle S Freeman; Kevin M Wissman; A Brianna Sheppard
Journal:  Psychopharmacology (Berl)       Date:  2012-10-23       Impact factor: 4.530

Review 10.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.